✦ LIBER ✦

Efficacy and safety of canagliflozin versus glimepiride in patients with type 2 diabetes inadequately controlled with metformin (CANTATA-SU): 52 week results from a randomised, double-blind, phase 3 non-inferiority trial

✍ Scribed by Cefalu, William T; Leiter, Lawrence A; Yoon, Kun-Ho; Arias, Pablo; Niskanen, Leo; Xie, John; Balis, Dainius A; Canovatchel, William; Meininger, Gary

Book ID: 120988402
Publisher: The Lancet
Year: 2013
Tongue: English
Weight: 489 KB
Volume: 382
Category: Article
ISSN: 0140-6736
DOI: 10.1016/S0140-6736(13)60683-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

2-year efficacy and safety of linaglipti

2-year efficacy and safety of linagliptin compared with glimepiride in patients with type 2 diabetes inadequately controlled on metformin: a randomised, double-blind, non-inferiority trial

✍ Baptist Gallwitz; Julio Rosenstock; Thomas Rauch; Sudipta Bhattacharya; Sanjay P 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 289 KB

Efficacy and safety of treatment with si

Efficacy and safety of treatment with sitagliptin or glimepiride in patients with type 2 diabetes inadequately controlled on metformin monotherapy: a randomized, double-blind, non-inferiority trial

✍ R. Arechavaleta; T. Seck; Y. Chen; K. J. Krobot; E. A. O’Neill; L. Duran; K. D. 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 594 KB

Efficacy and safety of canagliflozin mon

Efficacy and safety of canagliflozin monotherapy in Japanese patients with type 2 diabetes inadequately controlled with diet and exercise: a 24-week, randomized, double-blind, placebo-controlled, Phase III study

✍ Inagaki, Nobuya; Kondo, Kazuoki; Yoshinari, Toru; Takahashi, Nahoko; Susuta, Yut 📂 Article 📅 2014 🏛 Informa plc 🌐 English ⚖ 708 KB

Comparison of empagliflozin and glimepir

Comparison of empagliflozin and glimepiride as add-on to metformin in patients with type 2 diabetes: a 104-week randomised, active-controlled, double-blind, phase 3 trial

✍ Ridderstråle, Martin (author);Andersen, Knut Robert (author);Zeller, Cordula (au 📂 Article 📅 2014 🏛 Lancet Publishing Group 🌐 English ⚖ 597 KB

Comparison of empagliflozin and glimepir

Comparison of empagliflozin and glimepiride as add-on to metformin in patients with type 2 diabetes: a 104-week randomised, active-controlled, double-blind, phase 3 trial

✍ Ridderstråle, Martin (author);Andersen, Knut Robert (author);Zeller, Cordula (au 📂 Article 📅 2014 🏛 Lancet Publishing Group 🌐 English ⚖ 597 KB

Efficacy and safety of linagliptin 2.5 m

Efficacy and safety of linagliptin 2.5 mg twice daily versus 5 mg once daily in patients with type 2 diabetes inadequately controlled on metformin: a randomised, double-blind, placebo-controlled trial

✍ Ross, Stuart A.; Rafeiro, Elizabeth; Meinicke, Thomas; Toorawa, Robert; Weber-Bo 📂 Article 📅 2012 🏛 Informa plc 🌐 English ⚖ 254 KB